Fosun International LTD Decreased Chemocentryx (CCXI) Stake By $580,740; Tetra Technologies (TTI)’s Sentiment Is 0.98

ChemoCentryx, Inc. (NASDAQ:CCXI) Logo

Fosun International Ltd decreased Chemocentryx Inc (CCXI) stake by 36.51% reported in 2018Q4 SEC filing. Fosun International Ltd sold 58,074 shares as Chemocentryx Inc (CCXI)’s stock rose 6.99%. The Fosun International Ltd holds 100,976 shares with $1.06M value, down from 159,050 last quarter. Chemocentryx Inc now has $749.28 million valuation. The stock decreased 0.54% or $0.07 during the last trading session, reaching $12.98. About 6,860 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 12.22% since April 26, 2018 and is uptrending. It has outperformed by 7.85% the S&P500. Some Historical CCXI News: 09/03/2018 – CHEMOCENTRYX INC QUARTERLY SHR $0.80; 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M; 09/03/2018 – ChemoCentryx Intends to Initiate Clinical Development of Avacopan in Hidradenitis Suppurativa by Yr-En; 23/05/2018 – ChemoCentryx Announces Two Upcoming Presentations at the 55th ERA-EDTA Congress; 09/05/2018 – CHEMOCENTRYX INC – QTRLY DILUTED NET LOSS PER COMMON SHARE $0.19; 13/03/2018 – CHEMOCENTRYX INC CCXI.O : JP MORGAN RAISES TARGET PRICE TO $16 FROM $13; 09/05/2018 – CHEMOCENTRYX INC – EXPECTS TO UTILIZE CASH AND INVESTMENTS BETWEEN $65 MLN AND $75 MLN FOR TWELVE MONTHS ENDING DECEMBER 31, 2018; 09/03/2018 ChemoCentryx 4Q EPS 80c

Tetra Technologies Inc (TTI) investors sentiment decreased to 0.98 in Q4 2018. It’s down -0.14, from 1.12 in 2018Q3. The ratio is negative, as 64 funds started new and increased holdings, while 65 cut down and sold stock positions in Tetra Technologies Inc. The funds in our database now have: 100.87 million shares, up from 100.78 million shares in 2018Q3. Also, the number of funds holding Tetra Technologies Inc in top ten holdings was flat from 0 to 0 for the same number . Sold All: 24 Reduced: 41 Increased: 38 New Position: 26.

More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Globenewswire.com which released: “ChemoCentryx Appoints Rita Jain, M.D. to Board of Directors – GlobeNewswire” on March 28, 2019, also Globenewswire.com with their article: “Report: Exploring Fundamental Drivers Behind Lincoln National, News Corporation, Macerich, ChemoCentryx, Delek Logistics Partners, and SunCoke Energy Partners — New Horizons, Emerging Trends, and Upcoming Developments – GlobeNewswire” published on April 16, 2019, Benzinga.com published: “60 Stocks Moving In Wednesday’s Mid-Day Session – Benzinga” on March 27, 2019. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Benzinga.com and their article: “71 Biggest Movers From Yesterday – Benzinga” published on March 28, 2019 as well as Benzinga.com‘s news article titled: “10 Biggest Price Target Changes For Wednesday – Benzinga” with publication date: March 27, 2019.

Fosun International Ltd increased Vipshop Hldgs Ltd (NYSE:VIPS) stake by 3.02M shares to 7.71M valued at $42.12M in 2018Q4. It also upped Brookfield Asset Mgmt Inc (NYSE:BAM) stake by 13,500 shares and now owns 128,500 shares. Neurocrine Biosciences Inc (NASDAQ:NBIX) was raised too.

Among 5 analysts covering ChemoCentryx (NASDAQ:CCXI), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. ChemoCentryx had 5 analyst reports since November 12, 2018 according to SRatingsIntel. FBR Capital upgraded the stock to “Buy” rating in Wednesday, March 27 report. The stock of ChemoCentryx, Inc. (NASDAQ:CCXI) has “Buy” rating given on Tuesday, March 12 by H.C. Wainwright. The stock has “Buy” rating by Leerink Swann on Thursday, February 14. The rating was maintained by Canaccord Genuity on Monday, November 12 with “Buy”.

Since November 7, 2018, it had 0 insider purchases, and 6 sales for $1.47 million activity. Another trade for 20,170 shares valued at $242,370 was made by Schall Thomas J. on Monday, January 7. Shares for $74,079 were sold by Cappel Markus J.. On Tuesday, January 22 the insider KANAYA SUSAN M sold $457,747.

Investors sentiment decreased to 0.93 in Q4 2018. Its down 0.05, from 0.98 in 2018Q3. It worsened, as 7 investors sold CCXI shares while 38 reduced holdings. 18 funds opened positions while 24 raised stakes. 27.13 million shares or 1.23% more from 26.80 million shares in 2018Q3 were reported. Goldman Sachs Grp Inc reported 215,812 shares. Aqr Ltd Liability Corporation, a Connecticut-based fund reported 22,364 shares. American Grp has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Adams Diversified Equity Fund reported 38,600 shares stake. Ameriprise invested in 0% or 264,496 shares. Invesco Ltd stated it has 143,834 shares or 0% of all its holdings. Tiaa Cref Inv Mgmt holds 0% or 311,491 shares in its portfolio. California Employees Retirement System reported 67,452 shares. Cadence Capital Management Ltd Llc owns 0.11% invested in ChemoCentryx, Inc. (NASDAQ:CCXI) for 103,341 shares. D E Shaw And owns 214,899 shares or 0% of their US portfolio. Meeder Asset Mngmt stated it has 3,035 shares. Moreover, Arrowstreet Capital Lp has 0.01% invested in ChemoCentryx, Inc. (NASDAQ:CCXI). 6.69 million are held by Bvf Inc Il. California State Teachers Retirement Sys stated it has 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Sectoral Asset Inc stated it has 0.03% of its portfolio in ChemoCentryx, Inc. (NASDAQ:CCXI).

More notable recent TETRA Technologies, Inc. (NYSE:TTI) news were published by: Benzinga.com which released: “TETRA Technologies, Inc. Announces First Quarter 2019 Earnings Release Conference Call and Webcast – Benzinga” on April 18, 2019, also Seekingalpha.com with their article: “Tetra Technologies Q4 2018 Earnings Preview – Seeking Alpha” published on February 27, 2019, Seekingalpha.com published: “TETRA Technologies Inc. (TTI) CEO Stuart Brightman on Q4 2018 Results – Earnings Call Transcript – Seeking Alpha” on February 28, 2019. More interesting news about TETRA Technologies, Inc. (NYSE:TTI) were released by: Seekingalpha.com and their article: “Tetra Technologies: Raising My Price Target – Seeking Alpha” published on August 19, 2018 as well as Seekingalpha.com‘s news article titled: “TETRA Technologies CEO Brightman to retire, succeeded by Murphy – Seeking Alpha” with publication date: February 25, 2019.

Since January 1, 0001, it had 3 buys, and 0 selling transactions for $482,764 activity.

Analysts await TETRA Technologies, Inc. (NYSE:TTI) to report earnings on May, 14. They expect $-0.02 earnings per share, up 66.67% or $0.04 from last year’s $-0.06 per share. After $-0.01 actual earnings per share reported by TETRA Technologies, Inc. for the previous quarter, Wall Street now forecasts 100.00% negative EPS growth.

New Generation Advisors Llc holds 2.52% of its portfolio in TETRA Technologies, Inc. for 2.07 million shares. Prescott Group Capital Management L.L.C. owns 3.41 million shares or 1.12% of their US portfolio. Moreover, Adirondack Research & Management Inc. has 0.8% invested in the company for 764,860 shares. The Colorado-based Rk Capital Management Llc has invested 0.65% in the stock. Wealthtrust Axiom Llc, a Pennsylvania-based fund reported 852,670 shares.

The stock decreased 2.01% or $0.05 during the last trading session, reaching $2.44. About 13,283 shares traded. TETRA Technologies, Inc. (TTI) has declined 28.89% since April 26, 2018 and is downtrending. It has underperformed by 33.26% the S&P500. Some Historical TTI News: 04/05/2018 – TETRA BIO PHARMA – ELIGIBLE TO RECEIVE UPFRONT PAYMENT, MILESTONE PAYMENTS, SHARE OF PROFITS GENERATED BY SALES OF PPP001 IN PORTUGAL FROM AGREEMENT; 03/04/2018 – FDA Grants Orphan Drug Designation for Tetra Discovery Partners’ BPN14770 for the Treatment of Fragile X Syndrome; 06/03/2018 – GlaxoSmithKline: New Clinical Data Shows Efficacy of Fluarix Tetra; 08/05/2018 – TETRA TECHNOLOGIES INC TTI.N : RBC RAISES TARGET PRICE TO $5 FROM $4.50; 09/05/2018 – Tetra Technologies Short-Interest Ratio Rises 87% to 9 Days; 24/04/2018 – TETRA Market Size Worth $6.5 Billion by 2025 | CAGR: 17.8%: Grand View Research, Inc; 11/05/2018 – FUDO TETRA 1813.T 2017/18 GROUP RECURRING PROFIT 3.71 BLN YEN (-3.6 %), 2018/19 FORECAST PROFIT 3.20 BLN YEN (-13.7 %); 04/04/2018 – Tetra Bio-Pharma Initiates Enrolment of Patients in Phase 3 PPP001 Smokable Cannabis Pellet Study; 06/03/2018 – GSK: Phase III Trial with Fluarix Tetra Prevented Inflenza A, B in Children from 6-35 Months Old; 22/05/2018 – Tetra Technologies Presenting at JPMorgan Conference Jun 18

TETRA Technologies, Inc., together with its subsidiaries, operates as a diversified gas and oil services company. The company has market cap of $306.53 million. It operates through four divisions: Fluids, Production Testing, Compression, and Offshore. It currently has negative earnings. The Fluids division makes and markets clear brine fluids, additives, and associated services and products to the gas and oil industry for use in well drilling, completion, and workover activities in the United States, as well as in Latin America, Europe, Asia, the Middle East, and Africa.

TETRA Technologies, Inc. (NYSE:TTI) Institutional Positions Chart

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *